Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Throat cancer diagnosis could get faster and more accurate with new ultrasound technique

NCT ID NCT07548268

Diagnosis Sponsor: Tobias Todsen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a special ultrasound of the tonsils to standard exams helps doctors diagnose oropharyngeal cancer more accurately. About 180 patients with suspected throat cancer will be randomly assigned to either standard diagnostics alone or standard diagnostics plus the ultrasound. Researchers will compare how often the correct diagnosis is made, how many biopsies are successful, and how quickly the diagnosis is reached.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transoral and cervical ultrasound
What this could lead to
If successful, this could make diagnosing oropharyngeal cancer faster and more accurate, reducing the need for extra scans and repeat biopsies.
What could go wrong
This is a relatively small, early-stage study. The ultrasound technique may not prove consistently better than current methods, and results may not apply to all hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Referred to outpatient cancer clinic with one of the following: * A scan (MR, CT, PET/CT) suggesting malignancy in the oropharynx. This being asymmetric metabolic activity on PET/CT, a tumor or asymmetry of the palatine and lingual tonsils on MR and CT (7). * Tumor suspicious findings (erosion/ulcus, tonsil asymmetry/hypertrophy). * Tumor-suspicious symptoms (pain of the oropharynx) * \> 18 years of age. * Ability to understand and give informed consent. Exclusion Criteria: * • Prior oropharyngeal cancer * Prior radiation to the head and neck area

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Oropharyngeal carcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

oropharyngeal carcinoma oropharynx cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Oropharyngeal carcinoma Ultrasound

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of ORL - Head & Neck Surgery and Audiology, Zealand University Hospital,

    NOT_YET_RECRUITING

    Køge, Denmark

  • Department of Otorhinolaryngology, Head and Neck Surgery & Audiology

    RECRUITING

    Copenhagen, 2100, Denmark

  • Department of Otorhinolaryngology, Head and Neck Surgery & Audiology Northzealand Hospital

    NOT_YET_RECRUITING

    Hillerød, Denmark

  • Department of Otorhinolaryngology, Head and Neck Surgery, Aarhus University Hospital

    NOT_YET_RECRUITING

    Aarhus, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.